Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 24 Jul, 08:00 pm
Barclays increased its price target for Quest Diagnostics (NYSE:DGX) , indicating potential upside for the stock . The company reported robust second-quarter results with significant revenue growth and strong Adjusted earnings per share (EPS) . Quest Diagnostics has raised its fu
Investment firm HSBC initiated a "Hold" rating on Space Exploration Technologies (NASDAQ:SPCX), with the stock priced at $118.24 at the time of the rating. An upcoming lock-up expiry on August 4th will significantly increase the public float of SpaceX shares from an initial 4.9%
Rhinebeck Bancorp successfully completed its "second-step conversion," transitioning from a mutual holding company to a fully stock-based entity . The conversion included a stock split and a public offering that generated $88.8 million in gross proceeds from the sale of 8.88 mill
Intel (NASDAQ: INTC) Soars on Strong Q1 Earnings and AI-Driven Growth Intel reported strong Q1 financial performance, with earnings per share (EPS) doubling analyst estimates . The company achieved significant revenue growth of 25% year-over-year, marking its fastest growth rate
Revenue Forecast: Charter Communications anticipates a 1.77% decline in Q2 2026 revenue, signaling potential challenges for the telecommunications giant. EPS Outlook: Despite revenue pressures, earnings per share (EPS) are projected to rise by 10.78% , though analyst estimates ha
Leveraged exchange-traded funds (ETFs) and individual company stocks experienced significant declines due to various market pressures. Key drivers of the downturn included anticipation of earnings reports, high short interest, and corporate actions such as reverse stock splits. L
Market Movers: Analyzing Today's Top Stock Gainers and Their Drivers Strong financial results propelled NVE Corporation (NASDAQ: NVEC) to significant gains. Corporate actions, specifically reverse stock splits, were key drivers for Paranovus Entertainment (NASDAQ: PAVS) and Advan
Jefferies analyst raised the Thermo Fisher Scientific price target to $630.00 , suggesting a 10.02% upside. The company reported strong Q2 financial performance , with adjusted EPS of $6.03 and quarterly sales of nearly $12.00 billion , surpassing analyst expectations. Thermo Fis
RBC Capital has raised its price target for Argenx to $1,025 , maintaining an Outperform rating. The company reported robust Q2 product net sales of $1.5 billion , marking a 60% year-over-year increase, driven by strong Vyvgart performance. Argenx demonstrates consistent expansio
TotalEnergies (NYSE: TTE) reported an Earnings Per Share (EPS) of $2.68 , exceeding analyst estimates of $2.66 . The company's revenue reached $57.10 billion , surpassing the estimated $55.13 billion . Cash Flow From Operations (CFFO) stood at $9.80 billion , with adjusted net in
Analysts project earnings per share (EPS) of $1.27 and revenue between $35.16 billion and $35.31 billion for Verizon Communications (NYSE: VZ) 's Q2 earnings report. Verizon is undergoing significant operational restructuring, including store sales and job cuts, while maintaining
Analyst Caution: Price targets for Tenet Healthcare Corporation (NYSE:THC) have shown a downward trend, reflecting a more cautious market outlook. Q2 Earnings Factors: Upcoming second-quarter earnings reports for THC will be influenced by potential pressure from lower patient day
Barnes & Noble Education stock shows recent positive momentum with a 30-day gain of about 5.37% , despite a decline of approximately 8.75% over the last 10 days, potentially signaling an entry point for investors. Analysts project significant growth potential for Barnes & Noble E
Analyst confidence is growing, with average price targets increasing from $15.44 to $17.30 , signaling a positive market outlook for the banking institution . Strategic cost-cutting measures and a 17% reduction in New York real estate exposure are driving a turnaround, pointing t
Potential Buying Opportunity: A recent stock pullback of 5.56% may offer investors a lower entry point. Significant Growth Potential: Analysts project a stock price growth potential of 23.66% , with a target price of $261.16 . Robust Financial Health: The company boasts a strong
Jefferies analyst raises First Citizens BancShares (NASDAQ:FCNCA) price target to $2,300.00 , indicating a 4.35% upside. The bank reported strong Q2 2026 earnings of $57.09 per share , significantly beating estimates by over 41%. First Citizens BancShares demonstrated robust capi
Jefferies reiterated a "Buy" rating for Quest Diagnostics and raised its price target to $245.00 , signaling increased confidence in the company's future value. Quest Diagnostics reported robust Q2 adjusted EPS of $3.12 , a 19.1% year-over-year increase, significantly beating ana
Amalgamated Bank (NASDAQ: AMAL) Reports Strong Q2 2026 Financial Performance Amalgamated Bank (NASDAQ: AMAL) exceeded Q2 2026 earnings and revenue estimates, showcasing robust financial growth. The bank achieved record profitability with a net income of $34.8 million and maintain
Headlines provided by Investing.com